Product NDC: | 61703-327 |
Proprietary Name: | Dacarbazine |
Non Proprietary Name: | DACARBAZINE |
Active Ingredient(s): | 200 mg/1 & nbsp; DACARBAZINE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61703-327 |
Labeler Name: | Hospira Worldwide, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075940 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110923 |
Package NDC: | 61703-327-22 |
Package Description: | 1 VIAL in 1 CARTON (61703-327-22) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Code | 61703-327-22 |
Proprietary Name | Dacarbazine |
Package Description | 1 VIAL in 1 CARTON (61703-327-22) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Product NDC | 61703-327 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DACARBAZINE |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110923 |
Marketing Category Name | ANDA |
Labeler Name | Hospira Worldwide, Inc. |
Substance Name | DACARBAZINE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |